TY - JOUR
T1 - Spatial patterns of heterotopic ossification in fibrodysplasia ossificans progressiva correlate with anatomic temperature gradients
AU - Wang, Haitao
AU - De Cunto, Carmen L.
AU - Pignolo, Robert J.
AU - Kaplan, Frederick S.
N1 - Funding Information:
This work was supported in part by the International Fibrodysplasia Ossificans Progressiva Association (IFOPA), the Penn Center for Research in FOP and Related Disorders , the Ian Cali Endowment for FOP Research , the Whitney Weldon Endowment for FOP Research , and the Ashley Martucci FOP Research Fund (to FSK), The Robert and Arlene Kogod Professorship in Geriatric Medicine (to RJP), the Radiant Hope Foundation (to RJP) and The Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine (to FSK).
Publisher Copyright:
© 2021
PY - 2021/8
Y1 - 2021/8
N2 - Progressive heterotopic ossification (HO) is a hallmark of fibrodysplasia ossificans progressiva (FOP); however, this tissue transformation is not random. Rather, we noticed that HO in FOP progresses in well-defined but inexplicable spatial and temporal patterns that correlate precisely with infrared thermographs of the human body. FOP is caused by gain-of-function mutations in Activin A receptor type I (ACVR1/ALK2), a bone morphogenetic protein (BMP) type I receptor kinase. As with all enzymes, the activity of ACVR1 is temperature-dependent. We hypothesized that connective tissue progenitor cells that express the common heterozygous ACVR1R206H mutation (FOP CTPCs) exhibit a dysregulated temperature response compared to control CTPCs and that the temperature of FOP CTPCs that initiate and sustain HO at various anatomic sites determines, in part, the anatomic distribution of HO in FOP. We compared BMP pathway signaling at a range of physiologic temperatures in primary CTPCs isolated from FOP patients (n = 3) and unaffected controls (n = 3) and found that BMP pathway signaling and resultant chondrogenesis were amplified in FOP CTPCs compared to control CTPCs (p < 0.05). We conclude that the anatomic distribution of HO in FOP may be due, in part, to a dyregulated temperature response in FOP CTPCs that reflect anatomic location. While the association of temperature gradients with spatial patterns of HO in FOP does not demonstrate causality, our findings provide a paradigm for the physiologic basis of the anatomic distribution of HO in FOP and unveil a novel therapeutic target that might be exploited for this disabling condition.
AB - Progressive heterotopic ossification (HO) is a hallmark of fibrodysplasia ossificans progressiva (FOP); however, this tissue transformation is not random. Rather, we noticed that HO in FOP progresses in well-defined but inexplicable spatial and temporal patterns that correlate precisely with infrared thermographs of the human body. FOP is caused by gain-of-function mutations in Activin A receptor type I (ACVR1/ALK2), a bone morphogenetic protein (BMP) type I receptor kinase. As with all enzymes, the activity of ACVR1 is temperature-dependent. We hypothesized that connective tissue progenitor cells that express the common heterozygous ACVR1R206H mutation (FOP CTPCs) exhibit a dysregulated temperature response compared to control CTPCs and that the temperature of FOP CTPCs that initiate and sustain HO at various anatomic sites determines, in part, the anatomic distribution of HO in FOP. We compared BMP pathway signaling at a range of physiologic temperatures in primary CTPCs isolated from FOP patients (n = 3) and unaffected controls (n = 3) and found that BMP pathway signaling and resultant chondrogenesis were amplified in FOP CTPCs compared to control CTPCs (p < 0.05). We conclude that the anatomic distribution of HO in FOP may be due, in part, to a dyregulated temperature response in FOP CTPCs that reflect anatomic location. While the association of temperature gradients with spatial patterns of HO in FOP does not demonstrate causality, our findings provide a paradigm for the physiologic basis of the anatomic distribution of HO in FOP and unveil a novel therapeutic target that might be exploited for this disabling condition.
KW - ACVR1
KW - ALK2
KW - BMP pathway signaling
KW - Fibrodysplasia ossificans progressiva (FOP)
KW - Heterotopic ossification
UR - http://www.scopus.com/inward/record.url?scp=85104915704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104915704&partnerID=8YFLogxK
U2 - 10.1016/j.bone.2021.115978
DO - 10.1016/j.bone.2021.115978
M3 - Article
C2 - 33915334
AN - SCOPUS:85104915704
SN - 8756-3282
VL - 149
JO - Bone
JF - Bone
M1 - 115978
ER -